5-Azacytidine (NSC 102816) in refractory germ cell tumors - A phase II trial of the Eastern Cooperative Oncology Group

Bruce J. Roth, Paul Elson, George W. Sledge, Lawrence H. Einhorn, Donald L. Trump

Research output: Contribution to journalArticle

17 Scopus citations

Fingerprint Dive into the research topics of '5-Azacytidine (NSC 102816) in refractory germ cell tumors - A phase II trial of the Eastern Cooperative Oncology Group'. Together they form a unique fingerprint.